Back to Grantham, Mayo, Van Otterloo & Co. LLC Grantham, Mayo, Van Otterloo & Co. LLC

AMRXAMRX
10 quarters

Position history for Grantham, Mayo, Van Otterloo & Co. LLCGrantham, Mayo, Van Otterloo & Co. LLC's holdings in AMNEAL PHARMACEUTICALS INC

Grantham, Mayo, Van Otterloo & Co. LLC previously held 0 shares of AMRX (AMNEAL PHARMACEUTICALS INC), worth $0 as of 2023-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$846,000

Total Shares Change

-218,100

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q3
Latest
Exited
0
-100.0%
$00.0%$4.22
0
2023-Q2
Unchanged
23,100
0.0%
$71,6100.0%$2.87
0
2023-Q1
New
23,100
-
$32,1090.0%$1.36
27
2022-Q3
Exited
0
-100.0%
$00.0%$2.09
0
2022-Q2
Unchanged
146,500
0.0%
$466,0000.0%$3.32
0
2022-Q1
Increased
146,500
+500.4%
$611,0000.0%$4.22
39
2021-Q4
New
24,400
-
$117,0000.0%$4.86
30
2021-Q1
Exited
0
-100.0%
$00.0%$6.66
0
2020-Q4
Decreased
154,700
-29.1%
$707,0000.0%$4.60
0
2020-Q3
New
218,100
-
$846,0000.0%$3.85
34

Other major holders of AMRX: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, VANGUARD PORTFOLIO MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used